Health
AstraZeneca effective against Brazil variant – source – Daily Telegraph
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the Brazilian…
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the Brazilian variant of the disease. Colette Luke has more.
Continue Reading
-
Business23 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News20 hours agoWilliam Robinson dies aged 89
-
Business21 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business24 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.